Clinical Trial Update: Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates the safety, tolerability, and pharmacokinetics of MSP008-22 in patients with advanced solid tumors. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• MSP008-22

Snippet

Sponsor: Godavari Biorefineries Limited | Conditions: Advanced Solid Tumor | Phase 1 | Status: COMPLETED